New York, NY -- (SBWIRE) -- 01/21/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Antares Pharma Inc (NASDAQ:ATRS), Shanda Games Limited(ADR) (NASDAQ:GAME), Gerdau SA (ADR) (NYSE:GGB), Zalicus Inc (NASDAQ:ZLCS)
Antares Pharma Inc (NASDAQ:ATRS) showed a volume of 1.90 million shares by the end of last trade whereas the average volume of the stock remained 1.47 million shares. The stock opened the session at $4.91 but then moved to $4.83. At that price, the stock showed a negative performance of -1.43%. Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company’s subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors.
Will ATRS Get Buyers Even After The Recent Rally? Find Out Here
Shanda Games Limited(ADR) (NASDAQ:GAME) opened the session at $4.31 and closed the session at $4.77. The stock showed a positive performance of 10.67% in previous trading session. Traded with volume of 1.90 million shares in the prior session and the average volume of the stock remained 1.03 million shares. Shanda Games Limited (Shanda Games) is engaged in the development and operation of online games and related businesses in the People’s Republic of China. Some of its online games are also Web games, which the Company categorizes as either massively multiplayer online role-playing games (MMORPGs) or advanced casual games, rather than as a separate category of online games.
For How Long GAME will fight for Profitability? Read This Trend Analysis report
Gerdau SA (ADR) (NYSE:GGB) opened the session at $7.38 and closed the session at $7.39. The stock showed a positive performance of 0.27% in previous trading session. Traded with volume of 1.89 million shares in the prior session and the average volume of the stock remained 4.11 million shares. The beta of the stock remained 1.77. Gerdau SA is a Brazil-based holding company engaged in the manufacture and sale of steel products. The Company produces long steel and flat steel items, principally through the process of fabrication in electrical furnaces from scrap metal and purchased pig iron, as well as by manufacturing steel from iron ore in the blast furnace and by direct reduction.
Why Should Investors Buy GGB After The Recent Gain? Just Go Here and Find Out
Zalicus Inc (NASDAQ:ZLCS) the stock decreased 4.94% and finished the session at $1.70. Traded with volume of 1.89 million shares in the prior session and the average volume of the stock remained 1.39 million shares. The beta of the stock remained 1.69. Zalicus Inc. (Zalicus) is a biopharmaceutical company that discovers and developsl treatments for patients suffering from pain and immuno-inflammatory diseases.
Will ZLCS Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)